Vanguard Group Inc Nurix Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,465,507 shares of NRIX stock, worth $38.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,465,507

Previous 4,415,122 1.14%

Holding current value

$38.7 Million

Previous $52.5 Million 3.03%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$8.81 - $12.79 $443,891 - $644,424	50,385 Added 1.14%	4,465,507 $50.9 Million
Q1 2025 May 09, 2025	BUY	$11.88 - $20.15 $829,889 - $1.41 Million	69,856 Added 1.61%	4,415,122 $52.5 Million
Q4 2024 Feb 11, 2025	BUY	$18.64 - $28.14 $6.22 Million - $9.38 Million	333,452 Added 8.31%	4,345,266 $81.9 Million
Q3 2024 Nov 13, 2024	BUY	$18.93 - $25.69 $7.32 Million - $9.94 Million	386,800 Added 10.67%	4,011,814 $90.1 Million
Q2 2024 Aug 13, 2024	BUY	$12.02 - $21.3 $12.5 Million - $22.2 Million	1,040,714 Added 40.27%	3,625,014 $75.7 Million
Q1 2024 May 10, 2024	SELL	$7.77 - $15.66 $107,202 - $216,061	-13,797 Reduced 0.53%	2,584,300 $38 Million
Q4 2023 Feb 14, 2024	SELL	$4.25 - $10.71 $496,179 - $1.25 Million	-116,748 Reduced 4.3%	2,598,097 $26.8 Million
Q3 2023 Nov 14, 2023	BUY	$7.86 - $10.08 $179,239 - $229,864	22,804 Added 0.85%	2,714,845 $21.3 Million
Q2 2023 Aug 14, 2023	BUY	$8.7 - $13.28 $596,698 - $910,822	68,586 Added 2.61%	2,692,041 $26.9 Million
Q1 2023 May 15, 2023	BUY	$8.56 - $13.26 $3.6 Million - $5.58 Million	420,850 Added 19.11%	2,623,455 $23.3 Million
Q4 2022 Feb 10, 2023	BUY	$9.86 - $14.59 $411,546 - $608,972	41,739 Added 1.93%	2,202,605 $24.2 Million
Q3 2022 Nov 14, 2022	BUY	$12.33 - $19.81 $608,732 - $978,019	49,370 Added 2.34%	2,160,866 $28.2 Million
Q2 2022 Aug 12, 2022	BUY	$7.88 - $14.82 $657,452 - $1.24 Million	83,433 Added 4.11%	2,111,496 $26.8 Million
Q1 2022 May 13, 2022	BUY	$12.94 - $29.65 $485,237 - $1.11 Million	37,499 Added 1.88%	2,028,063 $28.4 Million
Q4 2021 Feb 14, 2022	BUY	$26.43 - $34.5 $333,361 - $435,148	12,613 Added 0.64%	1,990,564 $57.6 Million
Q3 2021 Nov 12, 2021	BUY	$22.71 - $36.69 $11.6 Million - $18.8 Million	511,814 Added 34.91%	1,977,951 $59.3 Million
Q2 2021 Aug 13, 2021	BUY	$24.21 - $35.89 $35.5 Million - $52.6 Million	1,466,137 New	1,466,137 $38.9 Million

Others Institutions Holding NRIX

# of Institutions

174

Shares Held

79.4M

Call Options Held

126K

Put Options Held

11.3K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $409M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Nurix Therapeutics, Inc. Transaction History